insider trading

SDM investors must join securities class action by March 16, 2026, alleging company misrepresented market manipulation and insider trading risks.

Tech executives at seven major companies sold $8.4B in stock despite record valuations, signaling possible concerns about current market pricing versus company fundamentals.

Rep. Tim Moore extends small-cap stock strategy into 2026 after achieving 52% portfolio gains in 2025, significantly outpacing the S&P 500.

Lumen director sells 45,000 shares amid telecom revenue decline. Company reported $12.4B revenue in 2025, down from prior year, while carrying $17B debt.

Class action lawsuit filed against Picard Medical for alleged securities fraud involving false statements, insider share sales, and social media misinformation to artificially inflate stock price.

PomDoctor faces class action lawsuit alleging fraudulent stock promotion scheme involving false statements, insider sales, and market manipulation between October-December 2025.

Bank of Hawaii director Robert Wo Jr. sold 5,000 shares worth $393,000 following the CEO's announced retirement in March 2026, amid the bank's stock decline.

Novanta CEO sells shares in routine plan sale. Stock up 23% YTD with strong growth, but elevated valuation concerns limit upside potential.

Phibro CEO Jack Bendheim sold $3.74M in stock via pre-planned trading agreement following strong Q2 results driven by expanded product portfolio and strategic acquisitions.

Cirrus Logic EVP sells $429K in stock amid strong earnings. Multiple executives engage in routine transactions, with the company's shares up 18% year-to-date.

Rosen Law Firm files securities class action against Smart Digital Group for alleged misrepresentations, insider sales, and concealed trading suspension risks. Investors with losses exceeding $100,000 invited to join by March 16, 2026.

Picard Medical securities lawsuit filing deadline is April 13, 2026. Class action alleges fraudulent stock promotion, insider selling, and artificial trading.

SentinelOne CEO sold $532K in shares via pre-arranged plan amid 43% stock decline. Stock trades at attractive valuations as company approaches $1B revenue milestone.

Pandora insiders and BlackRock expand shareholdings, signaling continued confidence in the jewelry manufacturer's strategic positioning and business trajectory.

Rosen Law Firm sues PomDoctor Ltd. for stock promotion fraud and misleading statements. Investors must act by April 7, 2026 deadline to join the class action.

Picard Medical faces securities fraud class action over misleading statements and stock promotion in 2025. Investors must file claims by April 3, 2026.

Class action lawsuit filed against Picard Medical for alleged fraud involving false social media statements and insider stock sales during inflated prices.

PomDoctor Ltd. faces securities lawsuit alleging false statements, social media manipulation, and insider selling. Investors who bought stock October-December 2025 must act before April 7, 2026 deadline.

Nokia executive David Heard sold 275,000 shares across multiple European exchanges for approximately 1.63 million EUR on February 16, 2026.

Maze Therapeutics CMO sold 15,000 shares via pre-arranged plan, completing divestiture. He retains 300,000 options while company maintains positive clinical momentum.